Emami Ltd reports robust domestic growth and strategic subsidiary performance, while navigating GST disruptions and male ...
Despite being saddled with tariffs and lagging behind China and the US, European sites offer biopharma suppliers a chance to diversify.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results